Targeting a specific metabolic pathway in the brain could offer new therapeutic avenues for rare neurodevelopmental disorders that devastate cognitive function. This research identifies how disrupted cellular energy sensing contributes to intellectual disability and points toward potential interventions that address root metabolic causes rather than just symptoms.
Investigators found that Rett syndrome mouse models exhibit excessive O-GlcNAcylation in hippocampal neurons—a nutrient-responsive modification that normally helps cells adapt their metabolism to energy availability. This biochemical imbalance appears linked to the syndrome's characteristic cognitive deficits and cellular energy problems. Treatment with OSMI-1, a compound that inhibits the enzyme responsible for adding these modifications, restored normal protein modification patterns in brain tissue. Treated mice showed improved performance on memory recognition tasks, better mitochondrial function, and reduced oxidative stress both in brain tissue and systemically.
This work connects two previously separate research threads: the known metabolic dysfunction in Rett syndrome and emerging evidence that O-GlcNAc modifications serve as crucial metabolic sensors in neurons. The findings suggest that intellectual disabilities in this condition may partly stem from cells' inability to properly gauge and respond to their energy status. While promising, these results remain limited to mouse models, and the safety profile of OGT inhibition in developing brains requires careful evaluation. The research represents an incremental but potentially significant step toward metabolic-based therapies for neurodevelopmental conditions, particularly given that current Rett syndrome treatments primarily manage symptoms rather than underlying cellular dysfunction.